






✨ Unlock your skin’s true clarity and confidence!
TOSOWOONG Arbutin 7 Tranexamic Acid 4 Cream is a potent, dermatologist-tested Korean skincare solution combining 7% Arbutin, 4% Tranexamic Acid, and Niacinamide to target dark spots, dullness, and wrinkles. Its lightweight, hypoallergenic formula suits all skin types, delivering visible brightening and firming results with consistent daily use.
























| ASIN | B0DPPL76XJ |
| ASIN | B0DPPL76XJ |
| Amazon Bestseller | #73,130 in Beauty ( See Top 100 in Beauty ) #2,786 in Facial Day Care |
| Color Name | アルブチン7%+トラネキサム酸4%クリーム |
| Customer Reviews | 4.2 4.2 out of 5 stars (3,472) |
| Date First Available | February 25, 2025 |
| Date First Available | February 25, 2025 |
| Item Form | Cream |
| Item model number | 8809179107877 |
| Manufacturer | MANTONG |
| Product Dimensions | 4.5 x 3 x 14 cm; 50 g |
| Product Dimensions | 4.5 x 3 x 14 cm; 50 g |
| Scent Name | Unscented |
| Skin Type | All skin types, sensitive skin, normal skin, mixed skin, dry skin, oily skin |
| Special Features | Travel Size |
| Target Gender | Unisex |
T**U
高いなだけ効果全然無かった、無くなるまで頑張って使えましたが、駄目だった👎
R**A
If you’re looking for an effective home-care product to help maintain your skin and manage pigmentation, this is a fantastic option. After having professional treatments for my melasma, I needed something reliable to help preserve my results and keep my skin looking bright and youthful. This cream is beautifully balanced for pigmentation-prone skin and melasma. The texture is light, absorbs quickly, and provides immediate hydration without any sticky or heavy feeling. Once it settles, my skin is left with a smooth, healthy, natural “glassy” glow. It’s become an essential part of my maintenance routine.
S**H
Very good quality
M**E
J’aime beaucoup.. elle donne un teint lumineux et mes taches se sont légèrement estompées
E**E
Very good seen results already.
K**O
Waste of money. It did nothing for me especially for the amount of money it costs. I will never buy again.
Trustpilot
3 weeks ago
3 weeks ago